前のページに戻る この文献は全文を取り寄せることができます
JDreamⅢ複写サービスから文献全文の複写(冊子体のコピー)をお申込みできます。
ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です。
既に、G-Searchデータベースサービスまたは、JDreamⅢのIDをお持ちの方
JDreamⅢ複写サービスのご利用が初めての方
取り寄せる文献のタイトルと詳細
文献
J-GLOBAL ID:201702265173370320   整理番号:17A1960423

限局性前立腺癌に対する抗アンドロゲン2 ヒドロキシフルトアミドの前立腺内修飾放出製剤【Powered by NICT】

An Intraprostatic Modified Release Formulation of Antiandrogen 2-Hydroxyflutamide for Localized Prostate Cancer
著者 (120件):
Tammela Teuvo L.
(Department of Urology, Tampere University Hospital and University of Tampere (TLT), Tampere, Finland)
Tammela Teuvo L.
(Department of Urology, Helsinki University Hospital (KT), Helsinki, Finland)
Tammela Teuvo L.
(Department of Urology, Paeijaet-Haeme Central Hospital (TI), Lahti, Finland)
Tammela Teuvo L.
(Department of Urology, Uppsala University Hospital (MH, SL), Uppsala, Sweden)
Tammela Teuvo L.
(Radiology, Department of Surgical Sciences (JW, CvB, CW), Uppsala University, Uppsala, Sweden)
Tammela Teuvo L.
(Department of Pharmacy (HL), Uppsala University, Uppsala, Sweden)
Tammela Teuvo L.
(Department of Immunology Genetics and Pathology (AT), Uppsala University, Uppsala, Sweden)
Tammela Teuvo L.
(LIDDS AB (NA, CGG), Uppsala, Sweden)
Tammela Teuvo L.
(Department of Oncology, University of OErebro (BL), OErebro, Sweden)
Haeggman Michael
(Department of Urology, Tampere University Hospital and University of Tampere (TLT), Tampere, Finland)
Haeggman Michael
(Department of Urology, Helsinki University Hospital (KT), Helsinki, Finland)
Haeggman Michael
(Department of Urology, Paeijaet-Haeme Central Hospital (TI), Lahti, Finland)
Haeggman Michael
(Department of Urology, Uppsala University Hospital (MH, SL), Uppsala, Sweden)
Haeggman Michael
(Radiology, Department of Surgical Sciences (JW, CvB, CW), Uppsala University, Uppsala, Sweden)
Haeggman Michael
(Department of Pharmacy (HL), Uppsala University, Uppsala, Sweden)
Haeggman Michael
(Department of Immunology Genetics and Pathology (AT), Uppsala University, Uppsala, Sweden)
Haeggman Michael
(LIDDS AB (NA, CGG), Uppsala, Sweden)
Haeggman Michael
(Department of Oncology, University of OErebro (BL), OErebro, Sweden)
Ladjevardi Sam
(Department of Urology, Tampere University Hospital and University of Tampere (TLT), Tampere, Finland)
Ladjevardi Sam
(Department of Urology, Helsinki University Hospital (KT), Helsinki, Finland)
Ladjevardi Sam
(Department of Urology, Paeijaet-Haeme Central Hospital (TI), Lahti, Finland)
Ladjevardi Sam
(Department of Urology, Uppsala University Hospital (MH, SL), Uppsala, Sweden)
Ladjevardi Sam
(Radiology, Department of Surgical Sciences (JW, CvB, CW), Uppsala University, Uppsala, Sweden)
Ladjevardi Sam
(Department of Pharmacy (HL), Uppsala University, Uppsala, Sweden)
Ladjevardi Sam
(Department of Immunology Genetics and Pathology (AT), Uppsala University, Uppsala, Sweden)
Ladjevardi Sam
(LIDDS AB (NA, CGG), Uppsala, Sweden)
Ladjevardi Sam
(Department of Oncology, University of OErebro (BL), OErebro, Sweden)
Taari Kimmo
(Department of Urology, Tampere University Hospital and University of Tampere (TLT), Tampere, Finland)
Taari Kimmo
(Department of Urology, Helsinki University Hospital (KT), Helsinki, Finland)
Taari Kimmo
(Department of Urology, Paeijaet-Haeme Central Hospital (TI), Lahti, Finland)
Taari Kimmo
(Department of Urology, Uppsala University Hospital (MH, SL), Uppsala, Sweden)
Taari Kimmo
(Radiology, Department of Surgical Sciences (JW, CvB, CW), Uppsala University, Uppsala, Sweden)
Taari Kimmo
(Department of Pharmacy (HL), Uppsala University, Uppsala, Sweden)
Taari Kimmo
(Department of Immunology Genetics and Pathology (AT), Uppsala University, Uppsala, Sweden)
Taari Kimmo
(LIDDS AB (NA, CGG), Uppsala, Sweden)
Taari Kimmo
(Department of Oncology, University of OErebro (BL), OErebro, Sweden)
Isotalo Taina
(Department of Urology, Tampere University Hospital and University of Tampere (TLT), Tampere, Finland)
Isotalo Taina
(Department of Urology, Helsinki University Hospital (KT), Helsinki, Finland)
Isotalo Taina
(Department of Urology, Paeijaet-Haeme Central Hospital (TI), Lahti, Finland)
Isotalo Taina
(Department of Urology, Uppsala University Hospital (MH, SL), Uppsala, Sweden)
Isotalo Taina
(Radiology, Department of Surgical Sciences (JW, CvB, CW), Uppsala University, Uppsala, Sweden)
Isotalo Taina
(Department of Pharmacy (HL), Uppsala University, Uppsala, Sweden)
Isotalo Taina
(Department of Immunology Genetics and Pathology (AT), Uppsala University, Uppsala, Sweden)
Isotalo Taina
(LIDDS AB (NA, CGG), Uppsala, Sweden)
Isotalo Taina
(Department of Oncology, University of OErebro (BL), OErebro, Sweden)
Lennernaes Hans
(Department of Urology, Tampere University Hospital and University of Tampere (TLT), Tampere, Finland)
Lennernaes Hans
(Department of Urology, Helsinki University Hospital (KT), Helsinki, Finland)
Lennernaes Hans
(Department of Urology, Paeijaet-Haeme Central Hospital (TI), Lahti, Finland)
Lennernaes Hans
(Department of Urology, Uppsala University Hospital (MH, SL), Uppsala, Sweden)
Lennernaes Hans
(Radiology, Department of Surgical Sciences (JW, CvB, CW), Uppsala University, Uppsala, Sweden)
Lennernaes Hans
(Department of Pharmacy (HL), Uppsala University, Uppsala, Sweden)
Lennernaes Hans
(Department of Immunology Genetics and Pathology (AT), Uppsala University, Uppsala, Sweden)
Lennernaes Hans
(LIDDS AB (NA, CGG), Uppsala, Sweden)
Lennernaes Hans
(Department of Oncology, University of OErebro (BL), OErebro, Sweden)
Weis Jan
(Department of Urology, Tampere University Hospital and University of Tampere (TLT), Tampere, Finland)
Weis Jan
(Department of Urology, Helsinki University Hospital (KT), Helsinki, Finland)
Weis Jan
(Department of Urology, Paeijaet-Haeme Central Hospital (TI), Lahti, Finland)
Weis Jan
(Department of Urology, Uppsala University Hospital (MH, SL), Uppsala, Sweden)
Weis Jan
(Radiology, Department of Surgical Sciences (JW, CvB, CW), Uppsala University, Uppsala, Sweden)
Weis Jan
(Department of Pharmacy (HL), Uppsala University, Uppsala, Sweden)
Weis Jan
(Department of Immunology Genetics and Pathology (AT), Uppsala University, Uppsala, Sweden)
Weis Jan
(LIDDS AB (NA, CGG), Uppsala, Sweden)
Weis Jan
(Department of Oncology, University of OErebro (BL), OErebro, Sweden)
von Below Catrin
(Department of Urology, Tampere University Hospital and University of Tampere (TLT), Tampere, Finland)
von Below Catrin
(Department of Urology, Helsinki University Hospital (KT), Helsinki, Finland)
von Below Catrin
(Department of Urology, Paeijaet-Haeme Central Hospital (TI), Lahti, Finland)
von Below Catrin
(Department of Urology, Uppsala University Hospital (MH, SL), Uppsala, Sweden)
von Below Catrin
(Radiology, Department of Surgical Sciences (JW, CvB, CW), Uppsala University, Uppsala, Sweden)
von Below Catrin
(Department of Pharmacy (HL), Uppsala University, Uppsala, Sweden)
von Below Catrin
(Department of Immunology Genetics and Pathology (AT), Uppsala University, Uppsala, Sweden)
von Below Catrin
(LIDDS AB (NA, CGG), Uppsala, Sweden)
von Below Catrin
(Department of Oncology, University of OErebro (BL), OErebro, Sweden)
Wassberg Cecilia
(Department of Urology, Tampere University Hospital and University of Tampere (TLT), Tampere, Finland)
Wassberg Cecilia
(Department of Urology, Helsinki University Hospital (KT), Helsinki, Finland)
Wassberg Cecilia
(Department of Urology, Paeijaet-Haeme Central Hospital (TI), Lahti, Finland)
Wassberg Cecilia
(Department of Urology, Uppsala University Hospital (MH, SL), Uppsala, Sweden)
Wassberg Cecilia
(Radiology, Department of Surgical Sciences (JW, CvB, CW), Uppsala University, Uppsala, Sweden)
Wassberg Cecilia
(Department of Pharmacy (HL), Uppsala University, Uppsala, Sweden)
Wassberg Cecilia
(Department of Immunology Genetics and Pathology (AT), Uppsala University, Uppsala, Sweden)
Wassberg Cecilia
(LIDDS AB (NA, CGG), Uppsala, Sweden)
Wassberg Cecilia
(Department of Oncology, University of OErebro (BL), OErebro, Sweden)
Lennernaes Bo
(Department of Urology, Tampere University Hospital and University of Tampere (TLT), Tampere, Finland)
Lennernaes Bo
(Department of Urology, Helsinki University Hospital (KT), Helsinki, Finland)
Lennernaes Bo
(Department of Urology, Paeijaet-Haeme Central Hospital (TI), Lahti, Finland)
Lennernaes Bo
(Department of Urology, Uppsala University Hospital (MH, SL), Uppsala, Sweden)
Lennernaes Bo
(Radiology, Department of Surgical Sciences (JW, CvB, CW), Uppsala University, Uppsala, Sweden)
Lennernaes Bo
(Department of Pharmacy (HL), Uppsala University, Uppsala, Sweden)
Lennernaes Bo
(Department of Immunology Genetics and Pathology (AT), Uppsala University, Uppsala, Sweden)
Lennernaes Bo
(LIDDS AB (NA, CGG), Uppsala, Sweden)
Lennernaes Bo
(Department of Oncology, University of OErebro (BL), OErebro, Sweden)
Tolf Anna
(Department of Urology, Tampere University Hospital and University of Tampere (TLT), Tampere, Finland)
Tolf Anna
(Department of Urology, Helsinki University Hospital (KT), Helsinki, Finland)
Tolf Anna
(Department of Urology, Paeijaet-Haeme Central Hospital (TI), Lahti, Finland)
Tolf Anna
(Department of Urology, Uppsala University Hospital (MH, SL), Uppsala, Sweden)
Tolf Anna
(Radiology, Department of Surgical Sciences (JW, CvB, CW), Uppsala University, Uppsala, Sweden)
Tolf Anna
(Department of Pharmacy (HL), Uppsala University, Uppsala, Sweden)
Tolf Anna
(Department of Immunology Genetics and Pathology (AT), Uppsala University, Uppsala, Sweden)
Tolf Anna
(LIDDS AB (NA, CGG), Uppsala, Sweden)
Tolf Anna
(Department of Oncology, University of OErebro (BL), OErebro, Sweden)
Axen Niklas
(Department of Urology, Tampere University Hospital and University of Tampere (TLT), Tampere, Finland)
Axen Niklas
(Department of Urology, Helsinki University Hospital (KT), Helsinki, Finland)
Axen Niklas
(Department of Urology, Paeijaet-Haeme Central Hospital (TI), Lahti, Finland)
Axen Niklas
(Department of Urology, Uppsala University Hospital (MH, SL), Uppsala, Sweden)
Axen Niklas
(Radiology, Department of Surgical Sciences (JW, CvB, CW), Uppsala University, Uppsala, Sweden)
Axen Niklas
(Department of Pharmacy (HL), Uppsala University, Uppsala, Sweden)
Axen Niklas
(Department of Immunology Genetics and Pathology (AT), Uppsala University, Uppsala, Sweden)
Axen Niklas
(LIDDS AB (NA, CGG), Uppsala, Sweden)
Axen Niklas
(Department of Oncology, University of OErebro (BL), OErebro, Sweden)
Golander Carl-Gustaf
(Department of Urology, Tampere University Hospital and University of Tampere (TLT), Tampere, Finland)
Golander Carl-Gustaf
(Department of Urology, Helsinki University Hospital (KT), Helsinki, Finland)
Golander Carl-Gustaf
(Department of Urology, Paeijaet-Haeme Central Hospital (TI), Lahti, Finland)
Golander Carl-Gustaf
(Department of Urology, Uppsala University Hospital (MH, SL), Uppsala, Sweden)
Golander Carl-Gustaf
(Radiology, Department of Surgical Sciences (JW, CvB, CW), Uppsala University, Uppsala, Sweden)
Golander Carl-Gustaf
(Department of Pharmacy (HL), Uppsala University, Uppsala, Sweden)
Golander Carl-Gustaf
(Department of Immunology Genetics and Pathology (AT), Uppsala University, Uppsala, Sweden)
Golander Carl-Gustaf
(LIDDS AB (NA, CGG), Uppsala, Sweden)
Golander Carl-Gustaf
(Department of Oncology, University of OErebro (BL), OErebro, Sweden)
Ahlstrom Hakan
(Department of Urology, Tampere University Hospital and University of Tampere (TLT), Tampere, Finland)
Ahlstrom Hakan
(Department of Urology, Helsinki University Hospital (KT), Helsinki, Finland)
Ahlstrom Hakan
(Department of Urology, Paeijaet-Haeme Central Hospital (TI), Lahti, Finland)

資料名:
Journal of Urology  (Journal of Urology)

巻: 198  号:ページ: 1333-1339  発行年: 2017年 
JST資料番号: B0074B  ISSN: 0022-5347  CODEN: JOURA  資料種別: 逐次刊行物 (A)
記事区分: 原著論文  発行国: オランダ (NLD)  言語: 英語 (EN)
JDreamⅢ複写サービスとは
JDreamⅢ複写サービスは、学術文献の全文を複写(コピー)して取り寄せできる有料サービスです。インターネットに公開されていない文献や、図書館に収録されていない文献の全文を、オンラインで取り寄せることができます。J-GLOBALの整理番号にも対応しているので、申し込みも簡単にできます。全文の複写(コピー)は郵送またはFAXでお送りします

※ご利用には、G-Searchデータベースサービスまたは、JDreamⅢのIDが必要です
※初めてご利用される方は、JDreamⅢ複写サービスのご案内をご覧ください。